Report #2833363

Received Mar 27, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: MD
Recovered: Unknown
Vaccinated: Mar 18, 2025
Onset: Mar 18, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARCEL	VARICELLA (VARIVAX)	MERCK & CO. INC.	UNK	Y011712	—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No symptomatic events reported; T/E for VARIVAX; This spontaneous report was received from a healthcare business professional and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 18-MAR-2025, the patient was administered Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), 0.5 ml, lot #Y011712, expiration date: 02-JUL-2026 (route of administration was not provided) for prophylaxis. The suspect vaccine was stored at 14.65 Fahrenheit (F) for 13 hours 15 minutes (product storage error). No adverse events were reported (no adverse event).

Other medications

Sterile diluent